arrow
返回
H

Huijun Xu

Hebei Medical University

36H指数
300论文数
5.1K被引数
收录论文 72
发表时间
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma自体人源化CD19 CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的安全性与有效性
err2025-08-20
err0
errOAAI
errYetian Dong; Tingting Yang; Mengyu Zhao; Fengmei Song; Rongrong Chen; Mingming Zhang; Ruimin Hong; Jingjing Feng; Shan Fu; Pingnan Xiao; Huijun Xu; Jiazhen Cui; Simao Huang; Guoqing Wei; Alex H. Chang; He Huang; Yongxian Hu
err分享
err收藏
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myelomaBCMA CAR-T细胞疗法在复发/难治性多发性骨髓瘤患者中的长期随访
err2025-03-28
err0
errOAAI
errJin, Chunxiang; Chen, Rongrong; Fu, Shan; Zhang, Mingming; Teng, Yuanyin; Yang, Tingting; Song, Fengmei; Feng, Jingjing; Hong, Ruimin; Cui, Jiazhen; Huang, Simao; Xu, Huijun; Zhang, Yanlei; Wei, Guoqing; Cai, Zhen; Kwong, Yok-Lam; Chan, Thomas Sau Yan; Chang, Alex H.; Huang, He; Hu, Yongxian
err分享
err收藏
err分享
err收藏
Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein
err2025-01-30
err0
errOAAI
errQiu, Qian; He, Zihan; Liu, Jing; Xu, Huijun; Wang, Jinyu; Liu, Nannan; Kang, Ning; Pan, Shaokun; Yu, Weien; Gao, Zixiang; Zhang, Shimei; Yang, Yang; Deng, Qiang; Xie, Youhua; Zhang, Jiming; Shen, Zhongliang
err分享
err收藏
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia序贯CD19和CD22 CAR-T疗法在复发/难治性成人B细胞急性淋巴细胞白血病中表现出显著的疗效和良好的安全性。
err2025-01-03
err0
errOAAI
errYang, Tingting; Dong, Yetian; Zhang, Mingming; Feng, Jingjing; Fu, Shan; Xiao, Pingnan; Hong, Ruimin; Xu, Huijun; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Kong, Delin; Geng, Jia; Chang, Alex H.; Huang, He; Hu, Yongxian
err分享
err收藏
Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia序贯CD19和CD22 CAR-T疗法在复发/难治性急性淋巴细胞白血病中的应用
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errYang, Tingting; Dong, Yetian; Zhang, Mingming; Feng, Jingjing; Fu, Shan; Xiao, Pingnan; Hong, Ruimin; Xu, Huijun; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Chang, Alex H.; Huang, He; Hu, Yongxian
err分享
err收藏
Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics
err2024-04-24
err0
errOAAI
errTan, Dan; Kang, Ning; Zhu, Yuanfei; Hou, Jia; Wang, Hanqing; Xu, Huijun; Zu, Cheng; Gao, Zixiang; Liu, Mu; Liu, Nannan; Deng, Qiang; Lu, Hongzhou; Liu, Jing; Xie, Youhua
err分享
err收藏
Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus肝内同源盒蛋白MSX-1是乙型肝炎病毒的新型宿主限制因子
err2024-02-20
err3
errOAAI
errShen, Zhongliang; Zhang, Shenyan; Gao, Zixiang; Yu, Xueping; Wang, Jinyu; Pan, Shaokun; Kang, Ning; Liu, Nannan; Xu, Huijun; Liu, Mu; Yang, Yang; Deng, Qiang; Liu, Jing; Xie, Youhua; Zhang, Jiming
err分享
err收藏
Preliminary efficacy and safety of SHR-2554 in advanced epithelioid sarcoma: A phase II trial
err2023-10-01
err0
errOAAI
errHu, H.; Zhou, Y.; Ding, X.; Zhang, Y.; Liang, J.; Xu, H.; Tian, L.; Zhao, C.
err分享
err收藏
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic ?d T-cell LymphomaHLA完全不匹配的同胞来源的CD7 car-t疗法过渡到单倍体造血干细胞移植治疗肝脾?d T细胞淋巴瘤
err2023-09-04
err2
errOAAI
errXu, Xueer; Zu, Cheng; Zhang, Mingming; Xiao, Pingnan; Hong, Ruimin; Feng, Jingjing; Xu, Huijun; Cui, Jiazhen; Yu, Jian; Shi, Jimin; Wei, Guoqing; Chang, Alex H.; Huang, He; Hu, Yongxian
err分享
err收藏